Clinical Trials Browser

Breast Neoplasms, Colonic Neoplasms, Esophageal Neoplasms, Gallbladder Neoplasms, Kidney Neoplasms, Liver Neoplasms, Meningioma, Multiple Myeloma, Neoplasms, Obesity, Ovarian Neoplasms, Pancreatic Neoplasms, Prostatic Neoplasms, Stomach Neoplasms, Thyroid Neoplasms, Endometrial Neoplasms

NCT06721715 2024-12-06

Textbook Outcomes After Oesophagectomy in Regional Australia

Not yet recruiting

100 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06712706 2024-12-04

Effect of Feeding Jejunostomy on Sarcopenia in Patients with Esophageal Cancer

Not yet recruiting

70 enrolled

Gastrointestinal

Esophageal Neoplasms, Sarcopenia

NCT06643689 2024-11-14

TAPES

Phase 2 Not yet recruiting

394 enrolled

Gastrointestinal

Esophageal Neoplasms, Esophageal Stenosis

NCT06681285 2024-11-08

CAR-RMEC

Phase 2 Not yet recruiting

51 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06662513 2024-11-05

Post Oesophagectomy Outcomes in a Single Regional Centre in Australia

Not yet recruiting

100 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06437288 2024-09-23

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

Phase 4 Not yet recruiting

198 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06468800 2024-08-28

TRACMOTION

Phase NA Not yet recruiting

20 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06558175 2024-08-16

REPAIR

Phase 1 Not yet recruiting

48 enrolled

GastrointestinalThoracic

Esophageal Neoplasms, Lung Neoplasms, Neoplasms

NCT06501664 2024-07-15

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Phase 3 Not yet recruiting

360 enrolled

Gastrointestinal

Esophageal Squamous Cell Carcinoma, Esophageal Neoplasms

NCT06484842 2024-07-03

Evaluation of the Effectiveness of the Combined Psychological Resilience and Self-efficacy Intervention for Improving Resilience and Self-efficacy and Reducing Anxiety and Depression of Oesophageal Cancer Surgery Patients

Phase NA Not yet recruiting

123 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06469060 2024-07-01

TRACE

Phase 2 Not yet recruiting

34 enrolled

Gastrointestinal

Adenocarcinoma, Esophageal Neoplasms

NCT06464614 2024-06-18

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

Phase 2 Not yet recruiting

54 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06418516 2024-05-17

ANGELA

Phase NA Not yet recruiting

340 enrolled

GastrointestinalHead & Neck

Carcinoma, Squamous Cell, Esophageal Neoplasms, Head and Neck Neoplasms

NCT06366685 2024-04-16

Recovery

Phase NA Not yet recruiting

60 enrolled

Gastrointestinal

Esophageal Neoplasms

NCT06312839 2024-03-15

Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning

Not yet recruiting

50 enrolled

Gastrointestinal

Esophageal Neoplasms, Anastomotic Leak

NCT04889742 2023-12-26

HETERERO

Phase 2 Not yet recruiting

110 enrolled

EndocrineGastrointestinalGenitourinaryGynecologicNETSarcoma

Hyperthermia, Anus Neoplasms, Carcinoma, Squamous Cell, Uterine Cervical Neoplasms, Esophageal Neoplasms, Fever, Pancreatic Neoplasms, Prostatic Neoplasms, Rectal Neoplasms, Recurrence, Sarcoma, Neuroendocrine Tumors

Clinical Trials

Outside the Cage (OTC) Robotic Esophagectomy

Clinical Study on Noninvasive Evaluation of Ivonescimab Antibody Distribution and Expression in Esophageal Cancer Patients by 89Zr-AK112 PET Imaging

The Value of Near-Infrared Fluorescence Imaging in the Protection of the Recurrent Laryngeal Nerve During Minimally Invasive Esophagectomy

ALDH2 Genetic Testing in East Asian Community

Indocyanine Green-guided Omental Shield Anastomosis for Cervical Esophagogastric Anastomosis in Minimally Invasive McKeown Esophagectomy

MRinRT

Stereotactic Body Radiation Therapy (SBRT) and Immunotherapy for Oligometastatic Esophageal Cancer

Studying the PAGODA Algorithm for Chemotherapy Dose Changes to Prevent Unplanned Treatment Delays

BRICES

MRD2START

AROMA2

GLOW

Patient-Reported Symptom Care Versus Usual Care After Esophageal Cancer Surgery: A Single-Center Phase 3 Randomized Trial

Non-intubated Versus Intubated Anesthesia in Thoracoscopic Esophagectomy for Esophageal Cancer

The Application of Symptoms Management Program Based on the Patient Reported Outcome After Esophagectomy

Health Informatics and Resistance Exercise for Symptom Management and Quality of Life in Post-Esophagectomy Patients

EC-CRT-008

Expectation, Pain Outcomes, and Pain Medication Following Oncology Abdominal Surgery: A Cohort Study

SEISMIC

INSECNT

Non-gastric Conduit Reconstruction After Esophagectomy

Tislelizumab Combined With Chemotherapy for the Perioperative Treatment of Esophageal Squamous Carcinoma

OMEC-5

Optimal Nutritional Palliation of Obstructed GEJ Cancer

Use of Different Enteral Feeds to Impact on Chyle Leaks in Oesophagectomy

The Effect of Neoadjuvant Chemoimmnotherapy Combined With Node Sparing Radiotherapy for cT3N+ EC

EUS Heparin

ATTENUATION

Efficacy of Tirellizumab Combined With Oral, Intravenous and Abdominal Chemotherapy in Peritoneal Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

Prognostic Analysis of Esophageal Cancer with Complete Pathological Response After Neoadjuvant Therapy

MOMENT

Thoraco-laparoscopic Partial Esophagogastrectomy for Management of Esophageal Cancer

Neoadjuvant Ivonescimab and Chemotherapy in Resectable Esophageal Cancer

Proteomic Analysis of Patients Undergoing Bariatric Surgery

Textbook Outcomes After Oesophagectomy in Regional Australia

Effect of Feeding Jejunostomy on Sarcopenia in Patients with Esophageal Cancer

TAPES

CAR-RMEC

Post Oesophagectomy Outcomes in a Single Regional Centre in Australia

Hematoporphyrin Photodynamic Therapy for Esophageal Cancer

TRACMOTION

REPAIR

Liposomal Irinotecan and 5-FU as Second-line Therapy for Patients With ESCC

Evaluation of the Effectiveness of the Combined Psychological Resilience and Self-efficacy Intervention for Improving Resilience and Self-efficacy and Reducing Anxiety and Depression of Oesophageal Cancer Surgery Patients

TRACE

Adebrelimab in Combination With Apatinib and Chemotherapy/Chemoradiotherapy in Immuno-experienced Second-line ESCC.

ANGELA

Recovery

Preoperative Arterial Embolization Before Oncologic Esophagectomy as a Technique for Ischemic Gastric Conditioning

HETERERO